Deeper Knowledge, Faster

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Harvard Business School
Queensland Health
Johnson and Johnson

Generated: January 16, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019445

« Back to Dashboard

NDA 019445 describes DEXTROSE 50% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare, Hospira, and Icu Medical Inc, and is included in five NDAs. It is available from five suppliers. Additional details are available on the DEXTROSE 50% IN PLASTIC CONTAINER profile page.

The generic ingredient in DEXTROSE 50% IN PLASTIC CONTAINER is dextrose. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.
Summary for 019445
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 019445
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DEXTROSE 25% dextrose INJECTABLE;INJECTION 019445 NDA Hospira, Inc. 0409-1775 0409-1775-10 10 CARTON in 1 PACKAGE (0409-1775-10) > 1 SYRINGE, PLASTIC in 1 CARTON > 10 mL in 1 SYRINGE, PLASTIC
DEXTROSE 25% dextrose INJECTABLE;INJECTION 019445 NDA Hospira, Inc. 0409-6648 0409-6648-02 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-6648-02) > 50 mL in 1 VIAL, SINGLE-DOSE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/ML
Approval Date:Jun 3, 1986TE:RLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength250MG/ML
Approval Date:Nov 23, 1998TE:RLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength500MG/ML
Approval Date:Sep 3, 2014TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Daiichi Sankyo
Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.